Current etf page

ETF Context

IHI ETF Context

News · Liquidity · Exposure · AIQ Momentum

Financial ServicesAsset ManagementScore data as of Sep 4, 2026

IHI

ETF Context
iShares U.S. Medical Devices ETF
Financial Services· Asset Management
AIQ Score
NeutralAIQ Edge 3/10
Low Priority
Relative Laggard
Score data as of Sep 4, 2026
Last price
$53.63
-$0.28 (-0.52%)
Latest market quote
Momentum46
Value30
Quality58
Risk Resilience69
Sentiment
View financial data

ETF Context Board

News pressure, liquidity, fund structure, exposure, and AIQ momentum context.

Inception date

ETF fund profile date from the ETF info snapshot.

AIQ Context
AIQ 48/100

Momentum 46/100 and sentiment beside current fund and news context.

Recent coverage
2 articles

Updated Sep 6, 2026 · Sentiment 9.20%

ETF Context Read

ETF context should explain what can change the setup and which AIQ component would move first.

Current ETF setup

Primary exposure

Largest available fund exposure bucket.

Expense ratio

Cost context that can affect long-term fund returns.

Average volume2.83M

Liquidity context for entry and exit conditions.

Holdings source date

Latest source date for reported holdings.

Holdings changeNot available

No reliable ETF buy/sell change feed in this snapshot.

Sentiment score

News pressure around the ETF setup.

Momentum score46

Where market reaction would show up first.

AIQ score48/100

Composite decision read before confirmation.

Fund context

Issuer

Fund sponsor from the ETF info snapshot.

Asset class

Broad asset class for the ETF.

Primary exposure

Largest available exposure bucket.

Fund size
$3.01B

Current assets under management when provided.

Expense ratio

Annual fund cost reported by the provider.

Holdings

Number of positions in the fund snapshot.

Average volume
2.83M

Liquidity context from the ETF info snapshot.

Holdings source date

Latest holder snapshot source date.

Holdings change
Not available

Current ETF holder rows do not include reliable buy/sell change fields.

Institutional report date

Latest downstream institutional-holder filing date.

Institutional share change
0

Net filing-reported change across available institutional holder rows.

Institutional Holder Changes

Filing-reported ETF share ownership changes by holder; this is not intraday flow or constituent trading.

Largest reported increases

No downstream institutional holder changes are available for this ETF yet.

Largest reported decreases

No downstream institutional holder changes are available for this ETF yet.

News And Sentiment

Recent ETF coverage, scored where source sentiment is available.

Positive
1
Neutral
1
Negative
0
zacks.com · Sep 2, 2026

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

Sector ETF report for IHI

seekingalpha.com · Aug 30, 2026

IHI: Limited Upside With Unfavorable Risk-Reward (NYSEARCA:IHI)

IHI's top three holdings—ABT, ISRG, and SYK—comprise nearly 43% of the portfolio, amplifying downside risk if growth falters. Read why IHI ETF is a Sell.

Open full news and sentiment

IHI ETF Context FAQ

What are the next catalysts for IHI stock?

IHI's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move IHI stock?

Upcoming events that could move IHI include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could IHI's next earnings report affect the stock?

IHI's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive IHI stock higher?

IHI could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt IHI stock?

IHI could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.